Adverse Drug Reactions
Adverse drug reactions can be considered a form of toxicity; however, toxicity is most commonly applied to effects of overingestion (accidental or intentional) or to elevated blood levels or enhanced drug effects that occur during appropriate use (eg, when drug metabolism is temporarily inhibited by a disorder or another drug). For information on toxicity of specific drugs see the table Symptoms and Treatment of Specific Poisons. Side effect is an imprecise term often used to refer to a drug’s unintended effects that occur within the therapeutic range. Because all drugs have the potential for adverse drug reactions, risk-benefit analysis (analyzing the likelihood of benefit vs risk of ADRs) is necessary whenever a drug is prescribed.
In the US, 3 to 7% of all hospitalizations are due to adverse drug reactions. ADRs occur during 10 to 20% of hospitalizations; about 10 to 20% of these ADRs are severe. These statistics do not include the number of ADRs that occur in ambulatory and nursing home patients. Although the exact number of ADRs is not certain, ADRs represent a significant public health problem that is, for the most part, preventable.
Related Conference of Adverse Drug Reactions
5th International conference on Vaccines, Vaccination and Immunization
Adverse Drug Reactions Conference Speakers
Recommended Sessions
- Adverse Drug Reactions
- Antibiotic Prophylaxis
- Antibiotic Regulatory Affairs
- Antibiotic Resistance: Opportunities and Challenges
- Antibiotics
- Antibiotics and Mechanism of Action
- Antibiotics for Emerging and Re-emerging Diseases
- Antibiotics for Various Diseases and Infections
- Antibiotics in Different Industries
- Antibiotics: In Pregnancy and Lactation
- Antibiotics: Market Analysis and Business Opportunities
- Antimicrobial Peptides
- Antimicrobial Therapy
- Applications of Antibiotics
- Bio Chemical Pharmacology
- Clinical Pharmacy and Pharmacotherapeutics
- Clinical Research Statistics
- Clinical Trials of Antibiotics
- Current Research in Antibiotic Resistance
- Developing Alternatives to Antibiotics
- Different Types of Antibiotics
- Drug Discovery and Novel Delivery Technologies
- Drug Safety Testing
- Drug Screening and Discovery
- Micro Organisms in Recent Drug Discovery
- MRSA
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs
- Pharmacology
- Pre-clinical and Clinical Trails
- Prevention and Control of Antibiotic Resistance
- The Emergence of Antimicrobial Resistance
- The Next Generation Approach of Antibiotics
- Toxicology
Related Journals
Are you interested in
- Cancer Immunology and Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Cell & Plant Biology - IMMUNOLOGY 2024 (Spain)
- Cell Biology - IMMUNOLOGY 2024 (Spain)
- CELL, ANIMAL & PLANT BIOLOGY - IMMUNOLOGY 2024 (Spain)
- Clinical Immunology & Current & Future Research - IMMUNOLOGY 2024 (Spain)
- Immune System - IMMUNOLOGY 2024 (Spain)
- Immuno informatics & Systems immunology - IMMUNOLOGY 2024 (Spain)
- Immuno-Genetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics - IMMUNOLOGY 2024 (Spain)
- Immunohistochemistry - IMMUNOLOGY 2024 (Spain)
- Immunology - IMMUNOLOGY 2024 (Spain)
- Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Nutritional Immunology - IMMUNOLOGY 2024 (Spain)
- OncoImmunology - IMMUNOLOGY 2024 (Spain)
- Pediatric and Neonatal Immunology - IMMUNOLOGY 2024 (Spain)
- Reproductive Immunology - IMMUNOLOGY 2024 (Spain)
- Transplantation and Computational Immunology - IMMUNOLOGY 2024 (Spain)
- Vaccines & Immunization - IMMUNOLOGY 2024 (Spain)
- Virology and infectious diseases - IMMUNOLOGY 2024 (Spain)